Copenhagen Atomics concludes its 2022 funding round
January 2023 — Copenhagen Atomics has raised US$21.6 million to accelerate the development of thorium molten salt reactors.
Copenhagen Atomics is developing a thorium molten salt reactor (MSR), which burns nuclear waste to create an abundance of affordable and green energy. MSRs operate with low-temperature and low-pressure fission nuclear technology, enabling the energy production to be safer and in significantly smaller production units when compared to conventional nuclear energy. The MSR reactor will be contained in 40-foot steel containers with a radiation shield and will generate the heat needed for electricity or ammonia production. MSR has the potential to provide the lowest cost of energy compared with any other energy technology.
Our role in the transaction
Oaklins’ team in Denmark assisted Copenhagen Atomics through its 2022 fundraising. During this process, the team executed and advised on many aspects, including, among others, marketing materials, investor dialogues and structuring.
Thomas Jam Pedersen
Co-founder, Copenhagen Atomics
Talk to the deal team
Kim Harpøth Jespersen
Oaklins Beierholm
Related deals
Nexxtlab has successfully raised funding to support its growth
Nexxtlab, a Luxembourg-based energy technology company, has raised growth capital from an experienced international energy player. The investment marks an important milestone in Nexxtlab’s development and will support the company’s commercial expansion across Europe, continued product innovation and the further scaling of its energy management platform.
Learn moreLemvig Biogasanlæg has been acquired by BioticNRG
BioticNRG has acquired Lemvig Biogasanlæg A.M.B.A. in a transaction that expands its presence in the biogas sector and establishes a strategic platform for further growth in the Danish renewable energy market. The acquisition supports the continued development of Lemvig Biogasanlæg while strengthening the production of green gas in Denmark.
Learn moreEmpresa Eléctrica Cochrane has completed a corporate restructuring and liability management process
AES Andes S.A. has completed a corporate restructuring and liability management process that included the acquisition of Toesca’s indirect interest in Empresa Eléctrica Cochrane S.p.A. (Cochrane); the prepayment of Cochrane AES’s 5.50% 2027 international bond; the exchange of Cochrane’s BCOCH-A local bonds for new international bonds issued in Rule 144A/Regulation S format for US$485 million; and the merger between Cochrane and AES Andes.
Learn more